Drug Type Small molecule drug |
Synonyms Venlafaxine deuterium-substituted |
Target |
Mechanism NET inhibitors(Norepinephrine transporter inhibitors), Serotonin reuptake inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H27NO2 |
InChIKeyPNVNVHUZROJLTJ-GQALSZNTSA-N |
CAS Registry940297-30-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder, Major | Phase 1 | - | - | |
Depressive Disorder, Major | Phase 1 | US | - | |
Neuralgia | Phase 1 | - | - | |
Neuralgia | Phase 1 | US | - | |
Neuralgia | Phase 1 | US | - | |
Neuralgia | Phase 1 | - | - |